Anti-Seizure Drug Targeted for Controlled Substance Restrictions

The popular pain and seizure drug gabapentin is under fire for its alleged role in America’s overdose crisis, with an influential consumer advocacy group urging the government to classify the prescription medication a controlled substance.

Almatica Pharma’s Gralise and Pfizer‘s Neorontin are among the brand-name drugs that would be under U.S. Drug Enforcement Administration watch should Public Citizen convince the government to categorize gabapentin and gabapentin enacarbil under Schedule V of the Controlled Substances Act.

Public Citizen is no stranger to calling on the government to classify prescription drugs as controlled substances. The group has petitioned for the DEA ...